Internal Medicine, Rheumatology · San Juan, PR
NPI
1538373535
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
369 Calle de Diego, Suite 210 Torre San Francisco
San Juan, PR, 00923
Phone (787) 756-6436
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.7M
3,370 prescriptions
Company payments, 2025
$1,088
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jose R Ramirez-Vazquez prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 583 prescriptions and refills. In total Jose R Ramirez-Vazquez wrote 3,370 Medicare prescriptions that cost $4.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 583 | 601 | 95 | $9,421 |
| Methylprednisolone Generic | 508 | 514 | 94 | $8,177 |
| Hydroxychloroquine Sulfate Generic | 362 | 414 | 69 | $9,576 |
| Celecoxib Generic | 287 | 303 | 81 | $7,278 |
| Humira(Cf) Pen Adalimumab | 233 | 233 | 27 | $1.6M |
| Enbrel Sureclick Etanercept | 174 | 174 | 24 | $1.3M |
| Duloxetine Hcl Generic | 119 | 132 | 28 | $1,354 |
| Pregabalin Generic | 114 | 114 | 24 | $2,928 |
| Mycophenolate Mofetil Generic | 72 | 78 | 13 | $4,787 |
| Prednisone Generic | 68 | 68 | 15 | $502 |
| Rinvoq Upadacitinib | 68 | 68 | Under 11 | $441K |
| Prolia Denosumab | 65 | 390 | 44 | $115K |
| Xeljanz Tofacitinib Citrate | 54 | 54 | Under 11 | $316K |
| Gabapentin Generic | 33 | 41 | 11 | $263 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 33 | 33 | Under 11 | $67K |
Brand drugs: - claims; generic drugs: 2,590 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose R Ramirez-Vazquez $1,088 ($1,088 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $439.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.